← All trials
NCT00735072
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2008
- Primary completion
- Apr 1, 2010
- Completion date
- Jul 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 45
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of California, San FranciscoLead sponsor
- AmFARCollaborator
- University of California, San FranciscoOverall official - principal investigator
- Stanford UniversityOverall official - principal investigator
- Case Western Reserve UniversityOverall official - principal investigator
- Rush UniversityOverall official - principal investigator
- PfizerCollaborator
- Stanford UniversityCollaborator
- Case Western Reserve UniversityCollaborator
- Rush UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.